Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-10-018994
Filing Date
2010-04-07
Accepted
2010-04-07 21:10:33
Documents
1
Period of Report
2010-04-05

Document Format Files

Seq Description Document Type Size
1 v180393_ex.html 3  
1 v180393_ex.xml 3 2140
  Complete submission text file 0001144204-10-018994.txt   3983
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHARMATHENE INC ONE PARK PLACE SUITE 450 ANNAPOLIS MD 21401
Business Address
FUERST THOMAS RICHARD (Reporting) CIK: 0001488331 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32587 | Film No.: 10738316